Literature DB >> 11551131

Cytoreductive surgery for ovarian cancer.

T C Randall1, S C Rubin.   

Abstract

Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with chemosensitive disease. Effective surgical management of ovarian cancer, therefore, requires competence in surgical anatomy and cytoreductive techniques and a thorough understanding of the patient's disease status and therapeutic goals.

Entities:  

Mesh：

Year:  2001        PMID： 11551131     DOI： 10.1016/s0039-6109(05)70171-7

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  10 in total

1.  Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.

Authors:  Mohamed A F Hegazy; Refaat A F Hegazi; Mohamed A Elshafei; Ahmed E Setit; Maged R Elshamy; Mohamed Eltatoongy; Amal A F Halim
Journal:  World J Surg Oncol       Date:  2005-08-31       Impact factor: 2.754

2.  The outcomes of intestinal resection during debulking surgery for ovarian cancer.

Authors:  Serdar Gökay Terzioğlu; Murat Özgür Kılıç; Nilüfer Çetinkaya; Eralp Baser; Tayfun Güngör; Cevdet Adıgüzel
Journal:  Turk J Surg       Date:  2017-06-01

3.  The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.

Authors:  Katherine C Brewer; Caryn E Peterson; Faith G Davis; Kent Hoskins; Heather Pauls; Charlotte E Joslin
Journal:  Ann Epidemiol       Date:  2015-04-18       Impact factor: 3.797

4.  Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients.

Authors:  Eddy Cotte; Olivier Glehen; Faheez Mohamed; Franck Lamy; Claire Falandry; François Golfier; Francois Noel Gilly
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

5.  Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.

Authors:  Arlene E Garcia-Soto; James J Java; Wilberto Nieves Neira; J Matthew Pearson; David E Cohn; Shashikant B Lele; Krishnansu S Tewari; Joan L Walker; Angeles Alvarez Secord; Deborah K Armstrong; Larry J Copeland
Journal:  Gynecol Oncol       Date:  2016-10-07       Impact factor: 5.482

6.  Hepatic resection for noncolorectal, nonneuroendocrine metastases.

Authors:  Fernando Cordera; David J Rea; Manuel Rodriguez-Davalos; Tanya L Hoskin; David M Nagorney; Florencia G Que
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

7.  Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer.

Authors:  Antonios-Apostolos K Tentes; Stylianos Kakolyris; Dimitrios Kyziridis; Christina Karamveri
Journal:  J Oncol       Date:  2012-02-09       Impact factor: 4.375

8.  Recreational physical activity and survival in African-American women with ovarian cancer.

Authors:  Sarah E Abbott; Fabian Camacho; Lauren C Peres; Anthony J Alberg; Elisa V Bandera; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Bo Qin; Ann G Schwartz; Jill Barnholtz-Sloan; Paul Terry; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-11-29       Impact factor: 2.532

9.  Preoperative colonoscopy in patients with a supposed primary ovarian cancer.

Authors:  Renata Raś; Edyta Barnaś; Joanna Skręt- Magierło; Anna Drozdzowska; Ewelina Bartosiewicz; Marek Sobolewski; Andrzej Skręt; Krzysztof Gutkowski
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

10.  Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer.

Authors:  Qiaqia Li; Yinghong Deng; Wei Wei; Fan Yang; An Lin; Desheng Yao; Xiaofeng Zhu; Jundong Li
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.